drugset / Trial / NCT02789813

Influence of Valproic Acid on Extinction-based Therapy in Patients With Fear of Spiders.

NCT02789813

Phase 2 Completed 100 enrolled University of Basel
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate whether valproic acid in combination with fear memory reactivation is useful to enhance treatment stability of exposure therapy for specific phobia.

Timeline

Start
2016-07
Primary completion
2018-06-30
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Valproic Acid Small molecule 500 mg Oral

Indications